Considerations about Genomic and Proteomic of (SARS-CoV)-2 and Concern Variants
DOI:
https://doi.org/10.33687/ricosbiol.01.01.015Keywords:
COVID-19 diagnosis, COVID19 clinical signs, radiography, serology, VOC, SARS-CoV-2Abstract
An unmatched coronavirus; termed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has been arisen in the end of 2019 in Wuhan, China resulted in a pandemic COVID-19 disease. In 2021, there were many mutations disseminated all over the world termed variants of concern. One of the critical main challenges is how to diagnose precisely the disease without confusion with another flu and respiratory distress causing viruses. The various clinical, radiological, laboratory, serological and molecular diagnostic approaches were discussed in this article.
Downloads
References
Adhikari SP, Meng S, Wu YJ et al., (2020): Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty,9: 29.
Ai T, Yang Z, Hou H et al.,(2020): Correlation of chest CT and RT‐PCR testing in coronavirus disease 2019 (COVID‐19) in China: a report of 1014 cases. Radiology 2019; 2020: 200642.
Alzamora M C, Paredes T, Caceres D, et al., (2020): Severe COVID-19 during Pregnancy and Possible Vertical Transmission. American Journal of Perinatology,s-0040-1710050. https://doi.org/10.1055/s-0040-1710050.
Annan A, Baldwin HJ, Corman VM, et al., (2013): Human beta-coronavirus 2c EMC/2012–related viruses in bats, Ghana and Europe. Emerg Infect Dis, 19 (3):456.
Benvenuto D, Giovanetti A, Ciccozzi S, et al., (2020): The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol,
Bernheim A, Mei X, Huang M, et al., (2020): Chest CT findings in coronavirus disease‐19 (COVID‐ 19): relationship to duration of infection. Radiology, 200463.
Bianchi M, Domenico B, Marta S, Pascarella A, et al., (2020): Sars-CoV-2 Envelope and Membrane Proteins: Differences from Closely Related Proteins Linked to Cross-species Transmission?Preprinted, April 2020.
Broughton J P, et al., (2020): CRISPR−Cas12-based detection of 779 SARS-CoV-2. Nat. Biotechnol. 2020.
Cai X, Chen J, Hu J, et al., (2020): A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19) medRxiv 2020.
Chan JF, Kok Z, Zhu H, et al., (2020): Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect, 9 (2020): 221-236.
Chan JFW, Yip CCY, To KKW, et al., (2020): Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. Journal of Clinical Microbiology, 58(5).
Chang Ch, Ming-Hon H, Chi-FonCh, et al., (2014): The SARS coronavirus nucleocapsid protein – Forms and functions. Antiviral Research, 103(3): 39-50.
Che XY, Qiu LW, Pan YX, et al., (2004): Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J. Clin. Microbiol.,42 (6): 2629–2635.
Chen H, Guo J, Wang C, et al., (2020): Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. The Lancet, 395(10226): 809–815.
Chen N, Zhou M, Dong X, et al., (2020): Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet395: 507– 13.
Chen Y, Liu Q, Guo D, et al., (2020): Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol.
Cheng MP, Papenburg J, Desjardins M, et al., (2020): Diagnostic testing for severe acute respiratory syndrome–related coronavirus-2: A narrative review. Annals of internal medicine.
Chu DK, Pan Y, Cheng SM, et al., (2020): Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clinical chemistry, 66(4): 549-555.
Corman VM, Landt O, Kaiser M, et al., (2020): Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3): 2000045.
Cui J, Li F, and Shi ZL, (2019): Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17: 181–192.
Cyril ChY, Chi-Chun H, Jasper FCh, et al., (2020): Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens. Int J Mol Sci. 21(7): 2574.
De-Ming Y, Tai-Jay Ch, Mong-Lien W, et al., (2020): Hunting coronavirus severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research. J Chin Med Assoc. 5: 10.
DeDiego ML, et al., (2011): Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS pathogens, 7: e1002315.
Desforges M, Le Coupanec A, Dubeau P, et al., (2020): Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses12: 14.
Diao B, Kun W, Jian C, et al., (2020): Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein. medRxiv 2020, 2020. doi: https://doi.org/10.1101/2020.03.07.20032524
Diao B, Wen K, Chen J, et al., (2020): Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of Nucleocapsid Protein, medRxiv 2020,
Diazyme Laboratories, Inc. Announces Availability of COVID-19 Antibody Tests, News & Media. Diazyme Laboratories, Inc. March 23, 2020. www.diazyme.com/diazyme-laboratories-inc-announces-availability-of-covid-19-antibody-tests
Dinesh DC, Chalupska D, Silhan J, et al., (2020): Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsidphosphoprotein.
Driggin E, Madhavan MV, Bikdeli B. et al., (2020): Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID‐19) pandemic. J Am CollCardiol, 75: 2352–71.
Egloff C, Vauloup-Fellous C, Picone O, et al., (2020): Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2. Journal of Clinical Virology, 128: 104447. https://doi.org/10.1016/j.jcv.2020.104447
Fang Li, (2020): Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology,3:237-261.
FDA Fact Sheet(2020): Serological testing for antibodies to SARS-CoV-2 infection. U.S. Food & Drug Administration, April 17, 2020: 1–2.
Fu X, Li D, and Sun Y, (2020): orf1ab polyprotein [Severe acute respiratory syndrome coronavirus 2] GenBank: QIA20042.1
Gao Y, Yan L, Huang Y, et al., (2020): Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science
Guan W‐j, Ni Z‐y, Hu Y, et al., (2020): Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020; 382: 1708–20.
Guo JP, Petric M, Campbell W, et al., (2004): SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology324: 251–256.
Guo X, Geng P, Wang Q, et al., (2014): Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus. J. Microbiol. Biotechnol. 24 (10): 1445–1454.
Gupta MK, Vemula S, Donde R, et al., (2020): In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1-17.
Hasöksüz M, Kiliç S, Saraç F, et al., (2020): Coronaviruses and SARS-COV-2.Turk J Med Sci. 50 (SI-1):549-556.
He F, Deng Y, Li W, (2020): Coronavirus disease 2019 (COVID‐19): What we know? J Med Virol, 2020.
Hinton DM, (2020): Emergency Use Authorization for qSARS-CoV-2 IgG/IgM Rapid Test (Cellex Inc.). U.S. Food & Drug Administration, April 1, 2020: 1–8
Huang C, Wang Y, Li X,et al., (2020): Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. The Lance , 395: 497–50.
Huang C, Yeming W, Xingwang L, et al., (2020): Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet Journal, 395 (10223): 497-506.
Iwen PC, Stiles KL, Pentella MA, (2020): Safety considerations in the laboratory testing of specimens suspected or known to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). American Journal of Clinical Pathology, 153(5): 567-570.
Ji W, Wang X, Zhao J, et al., (2020): Cross-species transmission of the newly identified coronavirus 2019- nCoV. J Med Virol, 92 : 433-440,
Jin Z, Du X, Xu Y, et al., (2020): Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature doi: 10.1038/s41586-020-2223-y.
Jones H, (2020): The Importance of diagnostic testing for COVID-19. Infectious Diseases Hub; April 2, 2020. www.id-hub.com/2020/04/02/the-importance-of-diagnostic-testing-for-covid-19/.
Kan B, Wang M, Jing H, et al., (2005): Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol, 79(18):11892–900.
Kang S, Yang M, Hong Z, et al., (2020): Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. ActaPharmaceuticaSinica B.doi: 10.1016/j.apsb.2020.04.009.
Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH.et al., (2020): Essentials for radiologists on COVID-19: an update radiology scientific expert panel. Radiology 2020; 200527.
Kim Y, Jedrzejczak R, Maltseva NI, et al., (2020): Crystal structure of Nsp15 endoribonucleaseNendoU from SARS‐CoV‐2. Protein Science.
Lai CC, Shih TP, Ko WC, et al., (2020): Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID19): the epidemic and the challenges. Int J Antimicrob Agents 2020:105924.
Lang G, Zhao H, et al., (2020): Can SARS-CoV-2-infected women breastfeed after viral clearance? Journal of Zhejiang University-SCIENCE B, 21(5): 405–407.
Lau SK, Li KS, Tsang AK, et al., (2013): Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol, 87(15):8638–50.
Lauer SA, Grantz KH, Bi Q, et al., (2020): The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of internal medicine. doi:10.7326/M20-0504.
Li B, Si H-R, Zhu Y, et al., (2020): Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next Generation Sequencing. mSphere, doi:10.1128/mSphere.00807-19
Li B, Yang J, Zhao F, et al., (2020): Prevalence and impact of cardiovascular metabolic diseases on COVID‐19 in China. Clin Res Cardiol, 109: 531– 38.
Li F, (2016): Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 3: 237–261.
Li Q, Guan P, Wu X, et al., (2020): Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med (2020), doi:10.1056/NEJMoa2001316
Li YC, Bai WZ, Hashikawa T,(2020): The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol.,92: 552– 5.
Lin Z, Gao Q, Qian F, et al., (2020): The nucleocapsid protein of SARS-CoV-2 abolished pluripotency in human induced pluripotent stem cells.bioRxivdoi.org/10.1101/2020.03.26.010694
Linda JC, Linda VG, Jeffrey WS, et al., (2020): Cynthia Liu Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Cent Sci, 27; 6(5): 591–605.
Littler D, Gully B, Colson RN, et al., (2020): Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9. bioRxiv.
Liu Y, Chen H, Tang K, et al., (2020): Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. Journal of Infection, S0163445320301092. https://doi.org/10.1016/j.jinf.2020.02.028
Lu R, Zhao X, Li J, et al., (2020): Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395(10224):565–574.
Mahase E, (2020): Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ 2020; 368: m1036.
Malika YS , Shubhankar S , Sudipta B, et al., (2020): Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments. Veterinary Quarterly40: (1), 68–76.
Malina A, John RM, Regina C, et al., (2013): Repurposing CRISPR/Cas9 for in situ functional assays. Genes Dev. 27(23): 2602–2614.
Max Perutz Labs, (2020): COVID-19 Q&A's - Max Perutz Labs.
Maxim DL, Niebo R, Utell MJ,et al.,(2014): Screening tests: a review with examples. Inhalation Toxicol. 26 (13), 811–828.
Meier C, Aricescu AR, Assenberg R, et al., (2006): The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus. Structure, 14(7):1157-65.
Millet JK and Whittaker GR, (2015): Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res.16 ( 202): 120–134.
Mizumoto K, Kagaya K, Zarebski A, et al., (2020): Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020: 25 (10).
Moore SC, Penrice-Randal R, Alruwaili M, et al., (2020): Amplicon based MinION sequencing of 820 SARS-CoV-2 and metagenomicscharacterisation of nasopharyngeal 821 swabs from patients with COVID-19. medRxiv 2020.
Muhammad AS, Suliman K, Abeer K, et al., (2020): COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res.24: 91–98.
National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/
National Institute of Biomedical Imaging and Bioengineering (NIBIB) https://www.nibib.nih.gov/science-education/science-topics/computed-tomography-ct
National Institute of Biomedical Imaging and Bioengineering, https://www.nibib.nih.gov/science-education/science-topics/computed-tomography-ct
Navratil V, Lionnard L, Longhi S, et al., (2020): The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like sequence. bioRxiv.
Neuman BW, Kiss G, Kunding AH, et al., (2011): Structural analysis of M protein in coronavirus assembly and morphology. Journal of Structural Biology. 174:11–22.
Paden C, Yusof M, Al Hammadi Z, et al., (2018): Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE. Zoonoses Public Health, 65(3):322–33.
Paraskevis D, Kostaki EG, Magiorkinis G, et al., (2020): Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol79:104212.
Pascarella G, Strumia A, Piliego C, et al., (2020): COVID-19 diagnosis and management: a comprehensive review.J Intern Med. 2020 Apr 29. doi.org/10.1111/joim.13091
PathSensors, Inc. Announced the Development of a SARS-CoV-2 Biosensor. PathSensorsInc, PathSensors News and Press, March 24, 2020. www.pathsensors.com/psi-sars-cov-2-biosensor/
Peng Q, Peng R, Yuan B, et al., (2020): Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from COVID-19 virus. bioRxiv.
Postnikova EN, Pettitt J, Van Ryn CJ, et al., (2019): Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples. PLoS One 14 (8):e0221407.
Qiu H, Wu J, Hong L, et al., (2020): Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet Infectious Diseases.doi:10.1016/S1473-3099(20)30198-5.
Renfei L, Xiuming W, Zhenzhou W, et al., (2020): Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2. Virol Sin. 2020 Apr: 1: 1–4.
Renhong Y, Yuanyuan Z, Yaning L, et al., (2020): Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 27; 367(6485): 1444–1448.
Robert NK and Ward AB, (2019): Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors .Nat Commun10: 2342.
Rota PA, Oberste MS, Monroe SS, et al., (2003): Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science.300 (5624):1394-9.
Ruan Q, Yang K, Wang W, et al., (2020): Clinical predictors of mortality due to COVID‐19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46(5):846-848.
Saahir K, Rie N, Aarti J, et al., (2020):Analysis of serologic cross-reactivity between common human coronaviruses and SARS-CoV-2 using coronavirus antigen microarray. bioRxiv 2020,
Schoeman D, and Fielding BC, (2019): Coronavirus envelope protein: current knowledge. Virology journal, 16(1): 69.
Shankar AK, Bhanu D, Alluri A, et al., (2020): Whole Genome Sequence Analysis and Homology Modelling of Main Protease and Non-Structural Protein 3 of the SARS-CoV-2 reveals an Aza-Peptide and a Lead Inhibitor with Possible Antiviral Properties. New Journal of Chemistry.doi.org/10.1039/D0NJ00974A.
Shannon A, Le NTT, Selisko B, et al., (2020): Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral Research, 104793.
Shen K, Yang Y, Wang T, et al., (2020): Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World journal of pediatrics, 1-9.
Shi Z, and Hu Z,(2008): A review of studies on animal reservoirs of the SARS coronavirus. Virus Res, 133 (1):74–87.
Song Z, Xu Y, Bao L, et al., (2019): From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses, 11: E59.
SunTand Guan J,(2020):Novel coronavirus and central nervous system. Eur J Neurol. org/10.1111/ene.14227.
Tan R,(2020): COVID-19 Diagnostics Explained.Asian Scientist; April 8, 2020.
Udugama B, Kadhiresan P, Kozlowski HN, et al., (2020): Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano, 14: 3822.
Uyaguari-Diaz MI, Michael Ch, Bonnie L, et al., (2016): A comprehensive method for ampliconbased and metagenomic characterization of viruses, bacteria, and eukaryotes in freshwater samples. Microbiome4:20.
Virus Pathogen Database and Analysis Resource, http://www.viprbrc.org/
Wang C, Horby PW, Hayden FG, et al., (2020): A novel coronavirus outbreak of global health concern. The Lancet395 (10223), DOI: 10.1016/S0140-6736(20)30185-9
Wang D, Hu B, Hu C, et al., (2020): Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 323(11): 1061-1069.
Wang W, Xu Y, Gao R, et al., (2020): Detection of SARS‐CoV‐2 in different types of clinical specimens. JAMA.323(18):1843-1844.
Wang WK, Fang CT, Chen HL, et al., (2005): Detection of severe acute respiratory syndrome coronavirus RNA in plasma during the course of infection. J. Clin. Microbiol. 43 (2), 962–965.
Whiteman MC, Antonello JM, Bogardus LA, et al., (2020): A virus neutralization assay utilizing imaging cytometry. WO 2020/036811, World Intellectual Property Organization, 20 February 2020.
World Health Organization, (2020): Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020, 2020.
World Health Organization,(2020):Novel coronavirus situation dashboard. Geneva, Switzerland: WHO, 2020.
Wu A, Peng Y, Huang B, et al., (2020): Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020.
Wu D, Wu T, Liu Q, et al., (2020): The SARS-CoV-2 outbreak: what we know. Int J Infect Dis, 94: 44–8.
Wu Z, and McGoogan JM. (2020): Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA323: 1239– 42.
X Xu, P Chen, J Wang, et al., (2020): Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci, 63(3):457-460.
Xiao AT, Tong YX, Gao C, et al., (2020): Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study. Journal of Clinical Virology, 104346.
Xie J, Tong Z, Guan X, et al., (2020): Critical care crisis and some recommendations during the COVID‐19 epidemic in China. Intens Care Med, 46: 579– 82.
Xu Z, Shi L, Wang Y et al., (2020): Pathological findings of COVID‐19 associated with acute respiratory distress syndrome. Lancet Resp Med, 8: 420– 2.
Yan C, Cui J, Huang L, et al., (2020): Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. Clinical Microbiology and Infection.26: 773-779.
Yang J, Zheng Y, Gou X, et al., (2020): Prevalence of comorbidities in the novel Wuhan coronavirus (COVID‐19) infection: a systematic review and meta‐analysis. International journal of infectious diseases.IJID 94: 91– 5.
Yang X, Yu Y, Xu J, et al., (2020): Clinical course and outcomes of critically ill patients with SARS‐CoV‐2 pneumonia in Wuhan, China: a single‐centered, retrospective, observational study. Lancet Resp Med,8: 475– 81.
Yi HS, Liu Y, Zhang Y, et al., (2020): A preliminary study on the ultrasonic manifestations of peripulmonary lesions of non‐critical novel coronavirus pneumonia (COVID‐19). Research square.
Yong Zhang CC, Zhu S, Shu C, et al., (2020): Isolation of 2019‐nCoV from a stool specimen of a laboratory‐confirmed case of the coronavirus disease 2019 (COVID‐19). China CDC Weekly, 2: 123–4.
Young BE, Ong SWX, Kalimuddin S, et al., (2020): Epidemiologic features and clinical course of patients infected with SARS‐CoV‐2.In Singapore. JAMA 323: 1488.
Zeng H, Xu C, Fan J, et al., (2020): Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA. doi.org/10.1001/jama.2020.4861
Zhang F, Abudayyeh OO, Gootenberg JS, et al., (2020): A protocol for 775 detection of COVID-19 using CRISPR diagnostics (v.20200321). 776 Broad Institute of MIT and Harvard. www.broadinstitute.org/files/ 777 publications/special/COVID-19
Zhang JJ, Dong X, Cao YY, et al., (2020): Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy.doi: 10.1111/all.14238.
Zhang L, Lin D, Sun X, et al., (2020): Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science, 368 (6489): 409-412.
Zhang W, Du R‐H, Li B, et al., (2020): Molecular and serological investigation of 2019‐nCoV infected patients: implication of multiple shedding routes. EmergMicrob Infect 9: 386–9.
Zheng BJ, Guan Y, Wong KH, et al., (2004): SARS-related virus predating SARS outbreak, Hong Kong. Emerg Infect Dis10 (2):176.
Zhou F, Yu T, Du R, et al., (2020): Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. The Lancet . 395: 1054– 62.
Zhou P, Yang XL, Wang XG, et al., (2020): Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv.
Zhu H, Wang L, Fang C, et al., (2020): Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational Pediatrics, 9(1): 51–60. https://doi.org/10.21037/tp.2020.02.06
Zhu N, Zhang D, Wang X, et al., (2020): A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med, 382 (2020): 727-733.
Zhuang GH, Shen MW, Zeng LX,et al., (2020): Potential false‐positive rate among the 'asymptomatic infected individuals' in close contacts of COVID‐19 patients. Zhonghua Liu Xing Bing XueZaZhi 41: 485–8.
Zou L, Ruan F, Huang M, et al., (2020): SARS‐CoV‐2 viral load in upper respiratory specimens of infected patients. N Engl J Med 382: 1177–9.
Published
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
